Reference number : GC-2017-Q4-01609, amendment number : , agreement type : G, recipient legal name : Sawan, Mohamad (École Polytechnique de Montréal), recipient country : CA, recipient province : nan, recipient city : Quebec|Québec, recipient postal code : nan, program name english : Engage Grants for universities, program name french : Subventions d'engagement partenarial pour les universités, program purpose english : Dymedso Company has been working for several years in the research and development of new medical_x000D_
technology, The FrequencerTM, to help patients affected by chronic respiratory diseases (CRDs) related to_x000D_
defective mucociliary clearance including cystic fibrosis (CF) and chronic bronchitis, among others._x000D_
The FrequencerTM, manufactured by Dymedso Company, is a digitally controlled acoustic airway clearance_x000D_
point-of-care (POC) device that promotes bronchial drainage by inducing vibrations in the chest wall of the_x000D_
patient. The FrequencerTM provides a gentler and less painful form of therapy than the traditional "clapping_x000D_
method" or postural drainage. The current and older versions of this device have received certifications from_x000D_
Health Canada, FDA, ISO 13485:2003, and UL for North America, Europe, Australia and New Zealand._x000D_
Dymedso is planning to introduce a new technology of its sound-wave generation therapy that addresses some_x000D_
issues identified by patients and caregivers over the past years of use in clinical practice. The identified issues_x000D_
involve ergonomic and performance limitations. For instance, the current version of the device is still_x000D_
cumbersome for patient use. Thus, for more practical and effective use, the device needs to be optimized in_x000D_
terms of size, weight, and overall performance. We will carefully analyze each of the modules composing The_x000D_
FrequencerTM including the sound-wave generator, the transducer, and the communication system to propose_x000D_
improvements for each of them. In addition, different types of sensors and feedback interfaces will be_x000D_
investigated for the new version in order to improve the effectiveness of this device., program purpose french : Dymedso Company has been working for several years in the research and development of new medical_x000D_
technology, The FrequencerTM, to help patients affected by chronic respiratory diseases (CRDs) related to_x000D_
defective mucociliary clearance including cystic fibrosis (CF) and chronic bronchitis, among others._x000D_
The FrequencerTM, manufactured by Dymedso Company, is a digitally controlled acoustic airway clearance_x000D_
point-of-care (POC) device that promotes bronchial drainage by inducing vibrations in the chest wall of the_x000D_
patient. The FrequencerTM provides a gentler and less painful form of therapy than the traditional "clapping_x000D_
method" or postural drainage. The current and older versions of this device have received certifications from_x000D_
Health Canada, FDA, ISO 13485:2003, and UL for North America, Europe, Australia and New Zealand._x000D_
Dymedso is planning to introduce a new technology of its sound-wave generation therapy that addresses some_x000D_
issues identified by patients and caregivers over the past years of use in clinical practice. The identified issues_x000D_
involve ergonomic and performance limitations. For instance, the current version of the device is still_x000D_
cumbersome for patient use. Thus, for more practical and effective use, the device needs to be optimized in_x000D_
terms of size, weight, and overall performance. We will carefully analyze each of the modules composing The_x000D_
FrequencerTM including the sound-wave generator, the transducer, and the communication system to propose_x000D_
improvements for each of them. In addition, different types of sensors and feedback interfaces will be_x000D_
investigated for the new version in order to improve the effectiveness of this device., agreement title english : Dymedso FrequencerTM Technology Optimization, agreement title french : Dymedso FrequencerTM Technology Optimization, agreement number : EGP, agreement value : 25000.0, agreement start date : 2018-03-07, agreement end date : nan, description english : nan, description french : nan, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year (2017-2018 to 2018-2019)., additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier (2017-2018 à 2018-2019)., owner organization : nserc-crsng, owner organization title : Natural Sciences and Engineering Research Council of Canada | Conseil de recherches en sciences naturelles et en génie du Canada